Carlton Haywood

Summary

Affiliation: Johns Hopkins Bloomberg School of Public Health
Country: USA

Publications

  1. ncbi A video-intervention to improve clinician attitudes toward patients with sickle cell disease: the results of a randomized experiment
    Carlton Haywood
    Division of Hematology, The Johns Hopkins University School of Medicine, The Johns Hopkins Berman Institute of Bioethics, Baltimore, MD 21205, USA
    J Gen Intern Med 26:518-23. 2011
  2. ncbi Examining the characteristics and beliefs of hydroxyurea users and nonusers among adults with sickle cell disease
    Carlton Haywood
    Department of Medicine, Division of Hematology, The Johns Hopkins School of Medicine, Baltimore, Maryland 21205, USA
    Am J Hematol 86:85-7. 2011
  3. ncbi Hospital self-discharge among adults with sickle-cell disease (SCD): associations with trust and interpersonal experiences with care
    Carlton Haywood
    Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
    J Hosp Med 5:289-94. 2010
  4. ncbi The association of provider communication with trust among adults with sickle cell disease
    Carlton Haywood
    Division of Hematology, The Johns Hopkins University School of Medicine, The Johns Hopkins Berman Institute of Bioethics, Baltimore, MD 21205, USA
    J Gen Intern Med 25:543-8. 2010
  5. ncbi A systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease
    Carlton Haywood
    Johns Hopkins Berman Institute of Bioethics, Johns Hopkins University School of Medicine, Division of Hematology, 2024 E Monument St, Rm 2 521, Baltimore, MD 21287, USA
    J Natl Med Assoc 101:1022-33. 2009
  6. ncbi Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children
    John J Strouse
    Department of Pediatrics, Johns Hopkins University School of Medicine, Division of Pediatric Hematology, 720 Rutland Ave, Ross 1125, Baltimore, MD 21205, USA
    Pediatrics 122:1332-42. 2008
  7. ncbi Religious coping and hospital admissions among adults with sickle cell disease
    Shawn M Bediako
    Department of Psychology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, MD 21250, USA
    J Behav Med 34:120-7. 2011
  8. ncbi Examining the effectiveness of hydroxyurea in people with sickle cell disease
    Sophie Lanzkron
    Div of Hematology, Dept of Medicine, Johns Hopkins University School of Medicine, 1830 E Monument Street, Suite 7300, Baltimore, MD 21205, USA
    J Health Care Poor Underserved 21:277-86. 2010
  9. ncbi The course and correlates of high hospital utilization in sickle cell disease: Evidence from a large, urban Medicaid managed care organization
    C Patrick Carroll
    Department of Psychiatry Behavioral Sciences, The Johns Hopkins School of Medicine, USA
    Am J Hematol 84:666-70. 2009
  10. ncbi Provider barriers to hydroxyurea use in adults with sickle cell disease: a survey of the Sickle Cell Disease Adult Provider Network
    Sophie Lanzkron
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    J Natl Med Assoc 100:968-73. 2008

Research Grants

  1. MINORITY PREDOCTORAL FELLOWSHIP PROGRAM
    Carlton Haywood; Fiscal Year: 2007

Detail Information

Publications18

  1. ncbi A video-intervention to improve clinician attitudes toward patients with sickle cell disease: the results of a randomized experiment
    Carlton Haywood
    Division of Hematology, The Johns Hopkins University School of Medicine, The Johns Hopkins Berman Institute of Bioethics, Baltimore, MD 21205, USA
    J Gen Intern Med 26:518-23. 2011
    ..Negative attitudes toward adults with sickle cell disease have been identified as an important barrier to the receipt of appropriate pain management for this patient population...
  2. ncbi Examining the characteristics and beliefs of hydroxyurea users and nonusers among adults with sickle cell disease
    Carlton Haywood
    Department of Medicine, Division of Hematology, The Johns Hopkins School of Medicine, Baltimore, Maryland 21205, USA
    Am J Hematol 86:85-7. 2011
    ..A deeper understanding of patient perspectives toward HU utilization is required as part of multipronged efforts to combat its underutilization in the treatment of SCD...
  3. ncbi Hospital self-discharge among adults with sickle-cell disease (SCD): associations with trust and interpersonal experiences with care
    Carlton Haywood
    Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
    J Hosp Med 5:289-94. 2010
    ....
  4. ncbi The association of provider communication with trust among adults with sickle cell disease
    Carlton Haywood
    Division of Hematology, The Johns Hopkins University School of Medicine, The Johns Hopkins Berman Institute of Bioethics, Baltimore, MD 21205, USA
    J Gen Intern Med 25:543-8. 2010
    ..Adults with sickle cell disease often report poor interpersonal healthcare experiences, including poor communication with providers. However, the effect of these experiences on patient trust is unknown...
  5. ncbi A systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease
    Carlton Haywood
    Johns Hopkins Berman Institute of Bioethics, Johns Hopkins University School of Medicine, Division of Hematology, 2024 E Monument St, Rm 2 521, Baltimore, MD 21287, USA
    J Natl Med Assoc 101:1022-33. 2009
    ....
  6. ncbi Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children
    John J Strouse
    Department of Pediatrics, Johns Hopkins University School of Medicine, Division of Pediatric Hematology, 720 Rutland Ave, Ross 1125, Baltimore, MD 21205, USA
    Pediatrics 122:1332-42. 2008
    ..Hydroxyurea is the only approved medication for the treatment of sickle cell disease in adults; there are no approved drugs for children...
  7. ncbi Religious coping and hospital admissions among adults with sickle cell disease
    Shawn M Bediako
    Department of Psychology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, MD 21250, USA
    J Behav Med 34:120-7. 2011
    ..29, P < .05). These results indicate a need for further investigation of the roles that religion and spirituality play in adjustment to sickle cell disease and their influence on health care utilization patterns and health outcomes...
  8. ncbi Examining the effectiveness of hydroxyurea in people with sickle cell disease
    Sophie Lanzkron
    Div of Hematology, Dept of Medicine, Johns Hopkins University School of Medicine, 1830 E Monument Street, Suite 7300, Baltimore, MD 21205, USA
    J Health Care Poor Underserved 21:277-86. 2010
    ..2,017, p=.031). Hydroxyurea was underutilized in this patient population. Patients with more regular refills of hydroxyurea had fewer admissions to the hospital and markedly decreased costs...
  9. ncbi The course and correlates of high hospital utilization in sickle cell disease: Evidence from a large, urban Medicaid managed care organization
    C Patrick Carroll
    Department of Psychiatry Behavioral Sciences, The Johns Hopkins School of Medicine, USA
    Am J Hematol 84:666-70. 2009
    ..Despite this, a small subpopulation engaged in exceptional levels of inpatient utilization over multiple years...
  10. ncbi Provider barriers to hydroxyurea use in adults with sickle cell disease: a survey of the Sickle Cell Disease Adult Provider Network
    Sophie Lanzkron
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    J Natl Med Assoc 100:968-73. 2008
    ..006). The results of this survey suggest that lack of awareness, agreement and belief in the benefits of hydroxyurea contributes to providers underprescribing hydroxyurea...
  11. ncbi Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease
    Sophie Lanzkron
    School of Medicine, Johns Hopkins University, 1830 East Monument Street, Suite 7300, Baltimore, MD 21205, USA
    Ann Intern Med 148:939-55. 2008
    ..Hydroxyurea is the only approved drug for treatment of sickle cell disease...
  12. ncbi Mortality rates and age at death from sickle cell disease: U.S., 1979-2005
    Sophie Lanzkron
    Johns Hopkins School of Medicine, Department of Medicine, Baltimore, MD 21205, USA
    Public Health Rep 128:110-6. 2013
    ..Whether similar improvements for adults with the disease have occurred is unknown. We investigated mortality rates for children and adults with SCD...
  13. ncbi Prediction of onset and course of high hospital utilization in sickle cell disease
    C Patrick Carroll
    Department of Psychiatry and Behavioral Sciences, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA
    J Hosp Med 6:248-55. 2011
    ..Although sickle cell disease (SCD) patients typically manage their pain at home, a small subgroup is frequently hospitalized and accounts for the majority of costs...
  14. ncbi Patient reactions to personalized medicine vignettes: an experimental design
    Morgan Butrick
    Department of Health, Behavior, and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21202, USA
    Genet Med 13:421-8. 2011
    ..This study describes patient responses to hypothetical conventional, race-based, or genetically personalized medicine prescriptions...
  15. ncbi Hospitalization rates and costs of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea
    Sophie Lanzkron
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Am J Hematol 81:927-32. 2006
    ..Hospital utilization among adults with SCA has increased significantly. There are likely many factors that have played a role in this increase. One factor that appears to be involved is the underutilization of HU...
  16. ncbi The impact of race and disease on sickle cell patient wait times in the emergency department
    Carlton Haywood
    Department of Medicine, Division of Hematology, The Johns Hopkins School of Medicine, Baltimore, MD 21205, USA
    Am J Emerg Med 31:651-6. 2013
    ....
  17. ncbi Venous Thromboembolism in Adults with Sickle Cell Disease: A Serious and Under-recognized Complication
    Rakhi P Naik
    Department of Medicine, Division of Hematology, Johns Hopkins University, Baltimore, Md Electronic address
    Am J Med 126:443-9. 2013
    ..The purpose of this study was to establish the prevalence and risk factors for venous thromboembolism in a large cohort of patients with sickle cell disease and determine the relationship between venous thromboembolism and mortality...
  18. ncbi A preliminary study of psychiatric, familial, and medical characteristics of high-utilizing sickle cell disease patients
    Patrick C Carroll
    Department of Psychiatry and Behavioral Sciences, The Johns Hopkins School of Medicine, Baltimore, MA, USA
    Clin J Pain 29:317-23. 2013
    ..To identify demographic, medical, and psychosocial characteristics that distinguished sickle cell disease (SCD) patients who were frequent utilizers of urgent or emergent care resources from low-utilizing patients...

Research Grants2

  1. MINORITY PREDOCTORAL FELLOWSHIP PROGRAM
    Carlton Haywood; Fiscal Year: 2007
    ..abstract_text> ..